Engineered skeletal muscles for disease modeling and drug discovery.

Biomaterials

Department of Biomedical Engineering, Duke University, Durham, NC, USA. Electronic address:

Published: November 2019

Skeletal muscle is the largest organ of human body with several important roles in everyday movement and metabolic homeostasis. The limited ability of small animal models of muscle disease to accurately predict drug efficacy and toxicity in humans has prompted the development in vitro models of human skeletal muscle that fatefully recapitulate cell and tissue level functions and drug responses. We first review methods for development of three-dimensional engineered muscle tissues and organ-on-a-chip microphysiological systems and discuss their potential utility in drug discovery research and development of new regenerative therapies. Furthermore, we describe strategies to increase the functional maturation of engineered muscle, and motivate the importance of incorporating multiple tissue types on the same chip to model organ cross-talk and generate more predictive drug development platforms. Finally, we review the ability of available in vitro systems to model diseases such as type II diabetes, Duchenne muscular dystrophy, Pompe disease, and dysferlinopathy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041662PMC
http://dx.doi.org/10.1016/j.biomaterials.2019.119416DOI Listing

Publication Analysis

Top Keywords

drug discovery
8
skeletal muscle
8
engineered muscle
8
drug
5
muscle
5
engineered skeletal
4
skeletal muscles
4
muscles disease
4
disease modeling
4
modeling drug
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!